All references are limited strictly to controlled laboratory research environments
Significant results In clinic trials, individuals using once weekly Semaglutide lost an average of 15% of their body weight, with 1 in 3 patients losing 20%+ in 68 weeks
Starch-based hydrogels, when cross-linked with other polymers, show structural stability and environmental responsiveness
Polymeric nanoparticles, especially those derived from PLGA (poly(lactic-co-glycolic acid)), have been used to prepare long-acting formulations of GLP-1 that can extend the release period to weeks with a single dose, reducing injection frequency and improving patient adherence [33]
Risks and Side Effects Emerging Concerns in India 1
Niu S, Bhatt P, Puyat V, Cohen J, Erickson K, editors